ArticlePostepy dermatologii i alergologii2026
Effects of red and blue light therapy combined with paroxetine on anxiety, depression and inflammatory factors in papulopustular rosacea.
Article in Postepy dermatologii i alergologii, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Papulopustular rosacea (PPR) remains a significant clinical and psychosomatic challenge in dermatological practice. Aim: To examine the clinical utility and interventional impact of red and blue light therapy in conjunction with paroxetine on serum inflammatory markers, anxiety, and depression in PPR patients. Material and methods: 120 PPR patients who were treated at our institution between May 2021 and March 2025 were the subject of a retrospective research. Patients were assigned to an observation group ( Results: In contrast to the control group, participants in the observation group exhibited markedly attenuated HAMA, HAMD, and IGA scores ( Conclusions: Combining paroxetine with red and blue light therapy can more effectively alleviate anxiety and depression, improve skin lesions, and reduce systemic inflammation levels, with a good safety profile. It is a promising treatment regimen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.